Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more
Navamedic ASA (NAVA) - Total Assets
Latest total assets as of September 2025: Nkr712.88 Million NOK
Based on the latest financial reports, Navamedic ASA (NAVA) holds total assets worth Nkr712.88 Million NOK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Navamedic ASA - Total Assets Trend (2003–2024)
This chart illustrates how Navamedic ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Navamedic ASA - Asset Composition Analysis
Current Asset Composition (December 2024)
Navamedic ASA's total assets of Nkr712.88 Million consist of 40.7% current assets and 59.3% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr36.08 Million | 7.6% |
| Accounts Receivable | Nkr55.91 Million | 11.4% |
| Inventory | Nkr81.89 Million | 16.7% |
| Property, Plant & Equipment | Nkr8.74 Million | 1.8% |
| Intangible Assets | Nkr92.56 Million | 18.8% |
| Goodwill | Nkr159.05 Million | 32.4% |
Asset Composition Trend (2003–2024)
This chart illustrates how Navamedic ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Navamedic ASA's current assets represent 40.7% of total assets in 2024, a decrease from 51.8% in 2003.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2024, down from 335.6% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 50.0% of total assets, an increase from 30.0% in 2003.
- Asset Diversification: The largest asset category is goodwill at 32.4% of total assets.
Navamedic ASA Competitors by Total Assets
Key competitors of Navamedic ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Navamedic ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Navamedic ASA generates 1.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Navamedic ASA generates $ 0.26 in net profit.
Navamedic ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.49 | 1.64 | 1.12 |
| Quick Ratio | 0.77 | 1.07 | 0.72 |
| Cash Ratio | 0.32 | 0.29 | 0.00 |
| Working Capital | Nkr77.97 Million | Nkr 102.83 Million | Nkr 12.29 Million |
Navamedic ASA - Advanced Valuation Insights
This section examines the relationship between Navamedic ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.43 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -6.3% |
| Total Assets | Nkr491.24 Million |
| Market Capitalization | $28.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Navamedic ASA's assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Navamedic ASA's assets decreased by 6.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Navamedic ASA (2003–2024)
The table below shows the annual total assets of Navamedic ASA from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr491.24 Million | -6.31% |
| 2023-12-31 | Nkr524.30 Million | +36.98% |
| 2022-12-31 | Nkr382.77 Million | +15.93% |
| 2021-12-31 | Nkr330.18 Million | +26.97% |
| 2020-12-31 | Nkr260.04 Million | +39.02% |
| 2019-12-31 | Nkr187.06 Million | -12.89% |
| 2018-12-31 | Nkr214.73 Million | -13.16% |
| 2017-12-31 | Nkr247.27 Million | -14.04% |
| 2016-12-31 | Nkr287.67 Million | +4.40% |
| 2015-12-31 | Nkr275.55 Million | +29.24% |
| 2014-12-31 | Nkr213.20 Million | +18.79% |
| 2013-12-31 | Nkr179.48 Million | +34.19% |
| 2012-12-31 | Nkr133.75 Million | -3.83% |
| 2011-12-31 | Nkr139.07 Million | +12.77% |
| 2010-12-31 | Nkr123.33 Million | -9.69% |
| 2009-12-31 | Nkr136.55 Million | -14.47% |
| 2008-12-31 | Nkr159.65 Million | -13.92% |
| 2007-12-31 | Nkr185.46 Million | +253.76% |
| 2006-12-31 | Nkr52.42 Million | +9.23% |
| 2005-12-31 | Nkr47.99 Million | +180.89% |
| 2004-12-31 | Nkr17.09 Million | +2116.74% |
| 2003-12-31 | Nkr770.79K | -- |